Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1258)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
505
Price
$560.49
Total Value
$283.05K
Shares Held After
41,375
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,399
Price
$559.76
Total Value
$1.90M
Shares Held After
41,880
% of Holdings
7.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,875
Price
$558.90
Total Value
$1.05M
Shares Held After
45,279
% of Holdings
4.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,096
Price
$557.78
Total Value
$611.32K
Shares Held After
47,154
% of Holdings
2.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
726
Price
$556.55
Total Value
$404.06K
Shares Held After
48,250
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
596
Price
$555.50
Total Value
$331.08K
Shares Held After
48,976
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
241
Price
$554.36
Total Value
$133.60K
Shares Held After
49,572
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$553.12
Total Value
$110.62K
Shares Held After
49,813
% of Holdings
0.4%
Butterfly Network, Inc. (BFLY)
DEVIVO JOSEPH — Director
Shares
204,725
Price
$7.87
Total Value
$1.61M
Shares Held After
7,883,844
% of Holdings
2.5%
Theravance Biopharma, Inc. (TBPH)
Samaha Eli — 10% Owner
Shares
5,564
Price
$17.17
Total Value
$95.54K
Shares Held After
9,167,489
% of Holdings
0.1%
Butterfly Network, Inc. (BFLY)
Doherty John N. — EVP, CFO
Shares
55,229
Price
$7.87
Total Value
$434.82K
Shares Held After
1,454,412
% of Holdings
3.7%
SOPHiA GENETICS SA (SOPH)
Camblong Jurgi — Director
Shares
17,685
Price
$5.28
Total Value
$93.33K
Shares Held After
3,541,122
% of Holdings
0.5%
MCKESSON CORP (MCK)
TYLER BRIAN S. — Director
Shares
8,463
Price
$793.56
Total Value
$6.72M
Shares Held After
5,919
% of Holdings
58.8%
ProQR Therapeutics N.V. (PRQR)
de Boer Daniel Anton — Director
Shares
150,000
Price
$1.59
Total Value
$238.50K
Shares Held After
150,000
% of Holdings
100.0%
MeiraGTx Holdings plc (MGTX)
Naylor Stuart — CHIEF SCI OFCR, OPHTHALMOLOGY
Shares
25,112
Price
$14.90
Total Value
$374.17K
Shares Held After
640,846
% of Holdings
3.8%
MeiraGTx Holdings plc (MGTX)
Naylor Stuart — CHIEF SCI OFCR, OPHTHALMOLOGY
Shares
2,547
Price
$13.86
Total Value
$35.30K
Shares Held After
665,958
% of Holdings
0.4%
Neurogene Inc. (NGNE)
Cvijic Christine Mikail — Director
Shares
4,200
Price
$36.13
Total Value
$151.76K
Shares Held After
84,040
% of Holdings
4.8%
Kymera Therapeutics, Inc. (KYMR)
Mainolfi Nello — Director
Shares
50,000
Price
$119.00
Total Value
$5.95M
Shares Held After
666,568
% of Holdings
7.0%
Immunome Inc. (IMNM)
Barchas Isaac — Director
Shares
16,906
Price
$24.20
Total Value
$409.13K
Shares Held After
108,504
% of Holdings
13.5%
Eton Pharmaceuticals, Inc. (ETON)
Opaleye Management Inc. — 10% Owner
Shares
6,685
Price
$38.37
Total Value
$256.52K
Shares Held After
53,315
% of Holdings
11.1%
Eton Pharmaceuticals, Inc. (ETON)
Opaleye Management Inc. — 10% Owner
Shares
20,000
Price
$38.37
Total Value
$767.46K
Shares Held After
2,680,000
% of Holdings
0.7%
CYTOKINETICS INC (CYTK)
Malik Fady Ibraham — EVP Research & Development
Shares
3,500
Price
$86.62
Total Value
$303.17K
Shares Held After
153,902
% of Holdings
2.2%
Xeris Biopharma Holdings, Inc. (XERS)
Pieper Steven — Chief Financial Officer
Shares
27,600
Price
$8.52
Total Value
$235.28K
Shares Held After
1,366,053
% of Holdings
2.0%
Showing 451–500 of 1258 transactions (page 10 of 26)